Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Anselmi

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|June 1, 1979
N-Methyl-benzylamine, a metabolite of pargyline in manR Pirisino, G B Ciottoli, F Buffoni, et al.
Cephalalgia : an International Journal of Headache|September 1, 1983
Impaired 5-hydroxytryptamine tachyphylaxis in migraineF Sicuteri, A Panconesi, G Franchi, et al.
International Journal of Clinical Pharmacology Research|January 1, 1984
Venospastic activity of somatostatin in vivo in man: naloxone reversible tachyphylaxisF Sicuteri, A Panconesi, P L Del Bianco, et al.
Advances in Experimental Medicine and Biology|January 1, 1976
Histamine and kallikrein system in manF Pedata, P L Del Bianco, C Curradi, et al.
Cephalalgia : an International Journal of Headache|August 1, 1983
Clinical pharmacological aspects of dihydroergotamine timed release: activity on monoamine venospasmG Franchi, B Anselmi, P L Del Bianco, et al.
Clinical Neuropharmacology|January 1, 1983
Naloxone reversal of 5-hydroxytryptamine tachyphylaxis in humansF Sicuteri, P L Del Bianco, B Anselmi, et al.
Clinical Pharmacology and Therapeutics|April 1, 1988
Effects of calcium antagonists on serotonin and noradrenaline venoconstriction in humansA Panconesi, G Franchi, B Anselmi, et al.
La Clinica Terapeutica|June 30, 1972
[5-Hydroxytryptamine and physiopathology of pain; on a polyalgic syndrome in the course of therapy with para-chlorophenylalanine]F Sicuteri, B Anselmi, G Franchi, et al.
Monographs in Neural Sciences|January 1, 1976
Monoamine oxidase defect in essential arterial hypertension. A single dose pargyline testB Anselmi, F Buffoni, C Curradi, et al.
Headache|April 1, 1994
Comparison between venoconstrictor effects of sumatriptan and ergotamine in migraine patientsA Panconesi, B Anselmi, C Curradi, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|June 1, 1979
N-Methyl-benzylamine, a metabolite of pargyline in manR Pirisino, G B Ciottoli, F Buffoni, et al.
Cephalalgia : an International Journal of Headache|September 1, 1983
Impaired 5-hydroxytryptamine tachyphylaxis in migraineF Sicuteri, A Panconesi, G Franchi, et al.
International Journal of Clinical Pharmacology Research|January 1, 1984
Venospastic activity of somatostatin in vivo in man: naloxone reversible tachyphylaxisF Sicuteri, A Panconesi, P L Del Bianco, et al.
Advances in Experimental Medicine and Biology|January 1, 1976
Histamine and kallikrein system in manF Pedata, P L Del Bianco, C Curradi, et al.
Cephalalgia : an International Journal of Headache|August 1, 1983
Clinical pharmacological aspects of dihydroergotamine timed release: activity on monoamine venospasmG Franchi, B Anselmi, P L Del Bianco, et al.
Clinical Neuropharmacology|January 1, 1983
Naloxone reversal of 5-hydroxytryptamine tachyphylaxis in humansF Sicuteri, P L Del Bianco, B Anselmi, et al.
Clinical Pharmacology and Therapeutics|April 1, 1988
Effects of calcium antagonists on serotonin and noradrenaline venoconstriction in humansA Panconesi, G Franchi, B Anselmi, et al.
La Clinica Terapeutica|June 30, 1972
[5-Hydroxytryptamine and physiopathology of pain; on a polyalgic syndrome in the course of therapy with para-chlorophenylalanine]F Sicuteri, B Anselmi, G Franchi, et al.
Monographs in Neural Sciences|January 1, 1976
Monoamine oxidase defect in essential arterial hypertension. A single dose pargyline testB Anselmi, F Buffoni, C Curradi, et al.
Headache|April 1, 1994
Comparison between venoconstrictor effects of sumatriptan and ergotamine in migraine patientsA Panconesi, B Anselmi, C Curradi, et al.
Pageof 4